HOLLYWOOD, Calif., May 14, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry-specific consulting services and patented systems to medical and retail businesses worldwide, commented on the federal tolerance of state regulated marijuana distribution programs.
The company's business strategy is specifically not to "touch" marijuana, but to provide the essential infrastructure to allow state departments of health (and similar state agencies) to monitor and regulate activity. To situate itself in a leadership position, the company has been avidly acquiring complimentary technologies to that of its existing line of products. Its seed-to-sale software and hardware do not facilitate growth or distribution of marijuana, but allow for tracking of these activities by operators and state regulators alike – an essential function of a well-regulated market. These nuances (facilitating the actual activity versus enabling tracking of the activity) are critical, and the company applies several internal tests when evaluating acquisition candidates, one of the most important being the company's intention to remain within what it perceives to be a safe harbor by not "touching" marijuana or facilitating its growth or distribution. The company provides tools that increase business efficiency and always enhance or promote regulatory compliance.
The company's recently filed Form 10 discusses the history of the Medbox machine. Our company's senior consultant and founder of the company's lead revenue generating subsidiary, Medicine Dispensing Systems, recognized the need for greater regulation and a system that could provide security. As a result, the Medbox was born. The company has consistently built upon that founder's experience to assure that future products would fit securely within a perceived safe ha
|SOURCE Medbox, Inc.|
Copyright©2012 PR Newswire.
All rights reserved